SCHEMBL20163948

SCHEMBL20163948

CCn1c(I)nc2c(Cl)ccnc21

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 4/20 0.33
ADORA3 P0DMS8 3/20 0.33
ADORA2A P29274 3/20 0.33
ADORA2B P29275 3/20 0.33
ADORA1 P30542 3/20 0.33
RPS6KA5 O75582 1/20 0.33
KDM4E B2RXH2 1/20 0.33
KMT2A Q03164 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
MAPT P10636 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
PTGER4 P35408 1/20 0.32
PDE4B Q07343 1/20 0.32
NOS1 P29475 1/20 0.31
NOS2 P35228 1/20 0.31
HSP90AA1 P07900 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15719168 0.75 ADORA2A (0.44) ADORA3ADORA2AADORA2BADORA1RPS6KA5
SCHEMBL18359503 0.75 PIK3CD (0.46) ADORA3ADORA2AADORA2BADORA1
SCHEMBL15720420 0.74 RPS6KA5 (0.53) HTR6RPS6KA5KDM4EKMT2ACYP1A2
SCHEMBL20176857 0.73 GRM5 (0.41) ADORA3ADORA2AADORA2BADORA1PDE4B
SCHEMBL11923720 0.69 HTR6 (0.39) HTR6
SCHEMBL4754879 0.69 HTR6 (0.40) HTR6KDM4EPDE4B
SCHEMBL18359407 0.69 PIK3CD (0.52) ADORA3ADORA2AADORA2BADORA1
SCHEMBL25270846 0.68 YTHDC1 (0.34) KDM4EKMT2ACYP1A2CYP3A4MAPT
SCHEMBL18359464 0.68 ADORA2A (0.49) HTR6ADORA2AADORA2BADORA1PDE4B
SCHEMBL20324668 0.67 GRM2 (0.39) KDM4EKMT2ACYP1A2CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3313397-B1 PURINE INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA MERCK SHARP & DOHME (US) 2020-11-25 EP disclosed
US-10221178-B2 Purine inhibitors of human phosphatidylinositol 3-kinase delta MERCK SHARP & DOHME CORP. (US) 2019-03-05 US disclosed
US-20180141947-A1 Purine Inhibitors of Human Phosphatidylinositol 3-Kinase Delta MERCK SHARP & DOHME CORP. (US) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10221178-B2 Purine inhibitors of human phosphatidylinositol 3-kinase delta PIK3CD, PIK3CA, PI4KA HTR6 3114/4885ADORA3 29/4885ADORA2A 84/4885
US-20180141947-A1 Purine Inhibitors of Human Phosphatidylinositol 3-Kinase Delta PIK3CD, PIK3CA, PI4KA HTR6 3114/4885ADORA3 29/4885ADORA2A 84/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.